Cargando…
Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome
Pathogenic RIPK1 variants have been described as the cause of two different inborn errors of immunity. Biallelic loss-of-function variants cause the recessively inherited RIPK1 deficiency, while monoallelic variants impairing the caspase-8-mediated RIPK1 cleavage provoke a novel autoinflammatory dis...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674708/ https://www.ncbi.nlm.nih.gov/pubmed/35716229 http://dx.doi.org/10.1007/s10875-022-01298-2 |
_version_ | 1784833209772539904 |
---|---|
author | Tapiz i Reula, Alfonso José Cochino, Alexis-Virgil Martins, Andreia L. Angosto-Bazarra, Diego de Landazuri, Iñaki Ortiz Mensa-Vilaró, Anna Cabral, Marta Baroja-Mazo, Alberto Baños, María C. Lobato-Salinas, Zulema Fabregat, Virginia Plaza, Susana Yagüe, Jordi Casals, Ferran Oliva, Baldomero Figueiredo, Antonio E. Pelegrín, Pablo Aróstegui, Juan I. |
author_facet | Tapiz i Reula, Alfonso José Cochino, Alexis-Virgil Martins, Andreia L. Angosto-Bazarra, Diego de Landazuri, Iñaki Ortiz Mensa-Vilaró, Anna Cabral, Marta Baroja-Mazo, Alberto Baños, María C. Lobato-Salinas, Zulema Fabregat, Virginia Plaza, Susana Yagüe, Jordi Casals, Ferran Oliva, Baldomero Figueiredo, Antonio E. Pelegrín, Pablo Aróstegui, Juan I. |
author_sort | Tapiz i Reula, Alfonso José |
collection | PubMed |
description | Pathogenic RIPK1 variants have been described as the cause of two different inborn errors of immunity. Biallelic loss-of-function variants cause the recessively inherited RIPK1 deficiency, while monoallelic variants impairing the caspase-8-mediated RIPK1 cleavage provoke a novel autoinflammatory disease (AID) called cleavage-resistant RIPK1-induced autoinflammatory (CRIA) syndrome. The aim of this study was to characterize the pathogenicity of two novel RIPK1 variants located at the cleavage site of caspase-8 detected in patients with dominantly-inherited, early-onset undefined AID. RIPK1 genotyping was performed by Sanger and next-generation sequencing. Clinical and analytical data were collected from medical charts, and in silico and in vitro assays were performed to evaluate the functional consequences. Genetic analyses identified two novel heterozygous RIPK1 variants at the caspase-8 cleavage site (p.Leu321Arg and p.Asp324Gly), which displayed a perfect intrafamilial phenotype-genotype segregation following a dominant inheritance pattern. Structural analyses suggested that these variants disrupt the normal RIPK1 structure, probably making it less accessible to and/or less cleavable by caspase-8. In vitro experiments confirmed that the p.Leu321Arg and p.Asp324Gly RIPK1 variants were resistant to caspase-8-mediated cleavage and induced a constitutive activation of necroptotic pathway in a similar manner that previously characterized RIPK1 variants causing CRIA syndrome. All these results strongly supported the pathogenicity of the two novel RIPK1 variants and the diagnosis of CRIA syndrome in all enrolled patients. Moreover, the evidences here collected expand the phenotypic and genetic diversity of this recently described AID, and provide interesting data about effectiveness of treatments that may benefit future patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10875-022-01298-2. |
format | Online Article Text |
id | pubmed-9674708 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-96747082022-11-20 Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome Tapiz i Reula, Alfonso José Cochino, Alexis-Virgil Martins, Andreia L. Angosto-Bazarra, Diego de Landazuri, Iñaki Ortiz Mensa-Vilaró, Anna Cabral, Marta Baroja-Mazo, Alberto Baños, María C. Lobato-Salinas, Zulema Fabregat, Virginia Plaza, Susana Yagüe, Jordi Casals, Ferran Oliva, Baldomero Figueiredo, Antonio E. Pelegrín, Pablo Aróstegui, Juan I. J Clin Immunol Original Article Pathogenic RIPK1 variants have been described as the cause of two different inborn errors of immunity. Biallelic loss-of-function variants cause the recessively inherited RIPK1 deficiency, while monoallelic variants impairing the caspase-8-mediated RIPK1 cleavage provoke a novel autoinflammatory disease (AID) called cleavage-resistant RIPK1-induced autoinflammatory (CRIA) syndrome. The aim of this study was to characterize the pathogenicity of two novel RIPK1 variants located at the cleavage site of caspase-8 detected in patients with dominantly-inherited, early-onset undefined AID. RIPK1 genotyping was performed by Sanger and next-generation sequencing. Clinical and analytical data were collected from medical charts, and in silico and in vitro assays were performed to evaluate the functional consequences. Genetic analyses identified two novel heterozygous RIPK1 variants at the caspase-8 cleavage site (p.Leu321Arg and p.Asp324Gly), which displayed a perfect intrafamilial phenotype-genotype segregation following a dominant inheritance pattern. Structural analyses suggested that these variants disrupt the normal RIPK1 structure, probably making it less accessible to and/or less cleavable by caspase-8. In vitro experiments confirmed that the p.Leu321Arg and p.Asp324Gly RIPK1 variants were resistant to caspase-8-mediated cleavage and induced a constitutive activation of necroptotic pathway in a similar manner that previously characterized RIPK1 variants causing CRIA syndrome. All these results strongly supported the pathogenicity of the two novel RIPK1 variants and the diagnosis of CRIA syndrome in all enrolled patients. Moreover, the evidences here collected expand the phenotypic and genetic diversity of this recently described AID, and provide interesting data about effectiveness of treatments that may benefit future patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10875-022-01298-2. Springer US 2022-06-18 2022 /pmc/articles/PMC9674708/ /pubmed/35716229 http://dx.doi.org/10.1007/s10875-022-01298-2 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Tapiz i Reula, Alfonso José Cochino, Alexis-Virgil Martins, Andreia L. Angosto-Bazarra, Diego de Landazuri, Iñaki Ortiz Mensa-Vilaró, Anna Cabral, Marta Baroja-Mazo, Alberto Baños, María C. Lobato-Salinas, Zulema Fabregat, Virginia Plaza, Susana Yagüe, Jordi Casals, Ferran Oliva, Baldomero Figueiredo, Antonio E. Pelegrín, Pablo Aróstegui, Juan I. Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome |
title | Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome |
title_full | Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome |
title_fullStr | Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome |
title_full_unstemmed | Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome |
title_short | Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome |
title_sort | characterization of novel pathogenic variants leading to caspase-8 cleavage-resistant ripk1-induced autoinflammatory syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674708/ https://www.ncbi.nlm.nih.gov/pubmed/35716229 http://dx.doi.org/10.1007/s10875-022-01298-2 |
work_keys_str_mv | AT tapizireulaalfonsojose characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT cochinoalexisvirgil characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT martinsandreial characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT angostobazarradiego characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT delandazuriinakiortiz characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT mensavilaroanna characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT cabralmarta characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT barojamazoalberto characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT banosmariac characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT lobatosalinaszulema characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT fabregatvirginia characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT plazasusana characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT yaguejordi characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT casalsferran characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT olivabaldomero characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT figueiredoantonioe characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT pelegrinpablo characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome AT arosteguijuani characterizationofnovelpathogenicvariantsleadingtocaspase8cleavageresistantripk1inducedautoinflammatorysyndrome |